Sale

Newborn Screening Market

Global Newborn Screening Market Size, Share, Growth, Trends, Forecast: Product Type: Instruments, Reagent’s & Assay Kits; By Technology: Tandem Mass Spectrometry, Pulse Oximetry, Enzyme Based Assays, DNA Assays, Electrophoresis, Others; By Test Type; By Diseases Type; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Newborn Screening Market Outlook

The global newborn screening market size attained a value of USD 1.20 billion in 2023. The market is likely to grow at a CAGR of 9% during the forecast period of 2024-2032, likely to attain a value of USD 2.60 billion by 2032.

 

Global Newborn Screening Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Measures to Prevent the Risk of Disease and Disability in Infants Aiding the Market Growth of Newborn Screening

The introduction of various measures by governments to prevent the risk of disability and disease among infants is aiding the market growth. For instance, the Kerala government in India announced that it would initiate universal Comprehensive Newborn Screening (CNS) for newborns in public health facilities in the state in June 2018. Moreover, the advancing healthcare industry in middle- and low-income countries is increasing the accessibility to screening for newborn babies, which is catalysing the market growth. As the treatments are increasingly becoming cost-effective owing to technological advancements, the demand for newborn screening among all socioeconomic classes is increasing. The growing awareness regarding the importance of screening for newborn babies among parents, as it can potentially lead to adversaries such as learning disabilities, autism, retardation, dyslexia, and behavioural abnormalities, among others, is also surging the demand for newborn screening, therefore strengthening the market growth.

 

Newborn Screening: Market Segmentation

Newborn screening refers to screening tests of infants to detect any disease or health adversaries that can be treated after identification. It is conducted through blood tests, heart screening, and hearing screening to identify underlying health conditions of an infant to improve the overall quality of its life.

 

Global Newborn Screening Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The major technologies of newborn screening are:

  • Tandem Mass Spectrometry
  • Pulse Oximetry 
  • Enzyme Based Assays
  • DNA Assays
  • Electrophoresis

The market can be broadly categorised on the basis of its test types into:

  • Dry Blood Spot Tests
  • Critical Congenital Heart Disease
  • Hearing Screening Tests

Based on product, the market is divided into:

  • Instruments
  • Reagents and Assay Kits

The EMR report looks into the regional markets of newborn screening like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Newborn Screening Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Development of Advanced Diagnostic Methods to Bolster the Growth of the Newborn Screening Industry

The development of complex and advanced diagnostic and screening methods to identify potential health conditions effectively is propelling the market growth. Moreover, the adoption of innovative technologies to diagnose genetic disorders and asymptomatic diseases for effective treatment of preventable and treatable diseases is augmenting the growth of the newborn screening industry. Although the market may be hindered due to the prevalence of false-positive and false-negative results, the increasing development of innovative and precise testing methods to eliminate the risk of false results is expected to significantly contribute to the market growth.

The rising deployment of components of molecular biology to analyse genetic mechanisms to detect diseases is invigorating the growth of the newborn screening industry. This is increasing the deployment of DNA microarray technology to increase the effectiveness of diagnosis, which is fuelling the market growth. In addition, the increasing research activities to minimise the side-effects of newborn screening methods while expanding the screening to diagnose more diseases is expected to provide impetus to the industry growth.

 

Key Industry Players in the Global Newborn Screening Market

The report presents a detailed analysis of the following key players in the global newborn screening market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Natus Medical, Inc.
  • Masimo Corporation
  • AB Sciex, LLC
  • Medtronic PLC
  • Intelligent Hearing Systems Corporation
  • Waters Corporation
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Technology
  • Test Type
  • Diseases Type
  • End User
  • Region
Breakup by Product Type
  • Instruments
  • Reagent’s & Assay Kits
Breakup by Technology
  • Tandem Mass Spectrometry
  • Pulse Oximetry
  • Enzyme Based Assays
  • DNA Assays
  • Electrophoresis
  • Others
Breakup by Test Type
  • Dry Blood Spot Test
  • Critical Congenital Heart Disease (CCHD)
  • Hearing Screen
  • Others
Breakup by Diseases Type
  • Critical Congenital Heart Diseases
  • New-born Hearing Loss
  • Sickle Cell Disease
  • Phenylketonuria (PKU)
  • Cystic Fibrosis (CF)
  • Maple Syrup Urine Disease
  • Others
Breakup by End User
  • Clinical Laboratory
  • Hospitals
  • Diagnostic Centre’s
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • PerkinElmer Inc.
  • Demant A/S
  • Natus Medical Incorporated
  • Bio-Rad Laboratories
  • Luminex Corporation
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
  • Bruker
  • Danaher
  • Medtronic
  • Chromsystems Instruments & Chemicals GmbH
  • Trivitron Healthcare
  • Baebies Inc
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope
    1.4    Research Methodology
2    Executive Summary
3    Global Newborn Screening Market Overview 

    3.1    Global Newborn Screening Market Historical Value (2017-2023) 
    3.2    Global Newborn Screening Market Forecast Value (2024-2032)
4    Global Newborn Screening Market Landscape
    4.1    Global Newborn Screening Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Newborn Screening Product Landscape
        4.2.1    Analysis by Product Type
        4.2.2    Analysis by Technology
        4.2.3    Analysis by End User
5    Global Newborn Screening Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Newborn Screening Market Segmentation 
    6.1    Global Newborn Screening Market by Product Type
        6.1.1    Market Overview
        6.1.2    Instruments
        6.1.3    Reagent’s & Assay Kits
    6.2    Global Newborn Screening Market by Technology
        6.2.1    Market Overview
        6.2.2    Tandem Mass Spectrometry
        6.2.3    Pulse Oximetry
        6.2.4    Enzyme Based Assays
        6.2.5    DNA Assays
        6.2.6    Electrophoresis
        6.2.7    Others
    6.3    Global Newborn Screening Market by Test Type
        6.3.1    Market Overview
        6.3.2    Dry Blood Spot Test
        6.3.3    Critical Congenital Heart Disease (CCHD)
        6.3.4    Hearing Screen
        6.3.5    Others
    6.4    Global Newborn Screening Market by Diseases Type
        6.4.1    Market Overview
        6.4.2    Critical Congenital Heart Diseases
        6.4.3    New-born Hearing Loss
        6.4.4    Sickle Cell Disease
        6.4.5    Phenylketonuria (PKU)
        6.4.6    Cystic Fibrosis (CF)
        6.4.7    Maple Syrup Urine Disease
        6.4.8    Others
    6.5    Global Newborn Screening Market by End User
        6.5.1    Market Overview
        6.5.2    Clinical Laboratory
        6.5.3    Hospitals 
        6.5.4    Diagnostic Centre’s
        6.5.5    Others
    6.6    Global Newborn Screening Market by Region
        6.6.1    Market Overview
        6.6.2    North America 
        6.6.3    Europe
        6.6.4    Asia Pacific
        6.6.5    Latin America
        6.6.6    Middle East and Africa
7    North America Newborn Screening Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Newborn Screening Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Newborn Screening Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Newborn Screening Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Newborn Screening Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Supplier Landscape
    16.1    PerkinElmer Inc.
        16.1.1    Financial Analysis
        16.1.2    Product Portfolio
        16.1.3    Demographic Reach and Achievements
        16.1.4    Mergers and Acquisitions
        16.1.5    Certifications
    16.2    Demant A/S
        16.2.1    Financial Analysis
        16.2.2    Product Portfolio
        16.2.3    Demographic Reach and Achievements
        16.2.4    Mergers and Acquisitions
        16.2.5    Certifications
    16.3    Natus Medical Incorporated
        16.3.1    Financial Analysis
        16.3.2    Product Portfolio
        16.3.3    Demographic Reach and Achievements
        16.3.4    Mergers and Acquisitions
        16.3.5    Certifications
    16.4    Bio-Rad Laboratories
        16.4.1    Financial Analysis
        16.4.2    Product Portfolio
        16.4.3    Demographic Reach and Achievements
        16.4.4    Mergers and Acquisitions
        16.4.5    Certifications
    16.5    Luminex Corporation
        16.5.1    Financial Analysis
        16.5.2    Product Portfolio
        16.5.3    Demographic Reach and Achievements
        16.5.4    Mergers and Acquisitions
        16.5.5    Certifications
    16.6    F. Hoffmann-La Roche Ltd.
        16.6.1    Financial Analysis
        16.6.2    Product Portfolio
        16.6.3    Demographic Reach and Achievements
        16.6.4    Mergers and Acquisitions
        16.6.5    Certifications
    16.7    Thermo Fisher Scientific Inc.
        16.7.1    Financial Analysis
        16.7.2    Product Portfolio
        16.7.3    Demographic Reach and Achievements
        16.7.4    Mergers and Acquisitions
        16.7.5    Certifications
    16.8    Bruker
        16.8.1    Financial Analysis
        16.8.2    Product Portfolio
        16.8.3    Demographic Reach and Achievements
        16.8.4    Mergers and Acquisitions
        16.8.5    Certifications
    16.9    Danaher
        16.9.1    Financial Analysis
        16.9.2    Product Portfolio
        16.9.3    Demographic Reach and Achievements
        16.9.4    Mergers and Acquisitions
        16.9.5    Certifications
    16.10    Medtronic
        16.10.1    Financial Analysis
        16.10.2    Product Portfolio
        16.10.3    Demographic Reach and Achievements
        16.10.4    Mergers and Acquisitions
        16.10.5    Certifications
    16.11    Chromsystems Instruments & Chemicals GmbH
        16.11.1    Financial Analysis
        16.11.2    Product Portfolio
        16.11.3    Demographic Reach and Achievements
        16.11.4    Mergers and Acquisitions
        16.11.5    Certifications
    16.12     Trivitron Healthcare
        16.12.1    Financial Analysis
        16.12.2    Product Portfolio
        16.12.3    Demographic Reach and Achievements
        16.12.4    Mergers and Acquisitions
        16.12.5    Certifications
    16.13     Baebies Inc
        16.13.1    Financial Analysis
        16.13.2    Product Portfolio
        16.13.3    Demographic Reach and Achievements
        16.13.4    Mergers and Acquisitions
        16.13.5    Certifications
17    Global Newborn Screening Market - Distribution Model (Additional Insight)
    17.1    Overview 
    17.2    Potential Distributors 
    17.3    Key Parameters for Distribution Partner Assessment 
18    Key Opinion Leaders (KOL) Insights (Additional Insight)
19    Company Competitiveness Analysis (Additional Insight)

    19.1    Very Small Companies
    19.2    Small Companies
    19.3    Mid-Sized Companies
    19.4    Large Companies
    19.5    Very Large Companies
20    Payment Methods (Additional Insight)
    20.1    Government Funded
    20.2    Private Insurance
    20.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the market attained a value of approximately USD 1.20 billion.

The market is expected to grow at a CAGR of 9% from 2024 to 2032 to reach a value of USD 2.60 billion by 2032.

The market is being aided by the improving health infrastructure in the developing countries and the growing cost-effectiveness of newborn screening.

The industry is expected to be driven by the growing development of advanced screening tests, the adoption of innovative technologies, and the increasing research activities to minimise the side-effects of newborn screening methods.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major technologies of newborn screening in the industry are tandem mass spectrometry, pulse oximetry, enzyme based assays, DNA assays, and electrophoresis.

The significant test types in the market are dry blood spot tests, critical congenital heart disease, and hearing screening tests.

The various products of newborn screening are instruments and reagents and assay kits.

The major players in the industry are Natus Medical, Inc., Masimo Corporation, AB Sciex, LLC, Medtronic PLC, Intelligent Hearing Systems Corporation, and Waters Corporation, among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER